GeorgeAndresVasquez RiosMDMSCR(He/Him)

Glomerular Disease, Hypertension, Clinical Informatics

Nephrologist, glomerular disease specialist and clinical researcher focused on precision medicine and health equity

Dr. Vasquez Rios is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. George Vasquez Rios is a nephrologist in New York, NY. He received his medical degree from Cayetano Heredia University followed by his Internal Medicine training at Saint Louis University School of Medicine. He has been in practice for +5 years. He also speaks multiple languages, including French and Spanish. He specializes in acute kidney injury, glomerular disease, and clinical research.

Icahn School of Medicine at Mount Sinai Masters of Science in Clinical Research, Biomarkers, prognostic models and translational methods in kidney health and disease, Graduated with distinction, 2021 - 2023
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2020 - 2023
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2017 - 2020
Cayetano Heredia UniversityClass of 2015, M.D

Alison Norris Award New York Society of Nephrology, 2023
Best Clinical Research Thesis Award Icahn School of Medicine at Mount Sinai, 2023
Editorial Intership American Journal of Kidney Diseases, 2023
Clinical Investigation Award National Institute of Health / NIDDK, 2023
Clinical Science Research Award New York Society of Nephrology, 2022
Kidney Stars Award American Society of Nephrology, 2018-2019
Innovations in Kidney Education Award American Society of Nephrology, 2018
Join now to see all

PubMed

2 citations
Urinary Biomarkers of Kidney Tubule Health and Mortality in Persons with CKD and Diabetes Mellitus.
George Vasquez-Rios, Ronit Katz, Emily B Levitan, Mary Cushman, Chirag R Parikh
Kidney360. 2023-09-01
4 citations
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Steven G Coca, George Vasquez-Rios, Sherry G Mansour, Dennis G Moledina, Heather Thiessen-Philbrook
American Journal of Kidney Diseases. 2023-02-01
5 citations
Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study.
George Vasquez-Rios, Dennis G Moledina, Yaqi Jia, Eric McArthur, Sherry G Mansour
Journal of Cardiothoracic Surgery. 2022-12-25

SGLT2 Inhibitors for the Management of IgA Nephropathy: A New Therapeutic Paradigm for an Old Entity?February 2022
SGLT2 Inhibition and Acute Kidney Injury Friend or Foe?October 2020
A 58-Year-Old Man With a Rash and Elevated Creatinine LevelsOctober 2019
FGF23 in AKI and CKD: Beyond phosphorus regulationApril 2019
Join now to see all

Google Scholar citationshttps://scholar.google.com/citations?user=WdHboxIAAAAJ&hl=en#
PubMedhttps://pubmed.ncbi.nlm.nih.gov/?term=Vasquez-Rios+G&sort=date